# Evaluation of Predictive Risk Factors of Persistent Hypertension in Hyperaldosteronism After Surgery

**Authors:** Amal Ourdi, Youssra Laalaoua, Imane Assarrar, Bouichrat Nisrine, Siham Rouf, Hanane Latrech

PMC · DOI: 10.5812/ijem-156728 · International Journal of Endocrinology and Metabolism · 2025-04-30

## TL;DR

This study identifies factors that predict whether hypertension will persist after surgery in patients with primary hyperaldosteronism.

## Contribution

The study introduces new predictive factors for persistent hypertension following PHA surgery, such as age and hypertension duration.

## Key findings

- Age > 50 years and hypertension duration > 5 years predict persistent hypertension after surgery.
- Lower preoperative blood pressure and higher glomerular filtration rate are linked to better post-surgery outcomes.
- Only 28.6% of patients reduced antihypertensive medication after surgery.

## Abstract

Primary hyperaldosteronism (PHA) is a common cause of secondary arterial hypertension (AH), characterized by autonomous aldosterone secretion. It is frequently underdiagnosed and may persist even after surgical intervention.

The present study aimed to identify preoperative factors that could predict whether hypertension would persist or normalize following surgery and to outline relevant diagnostic characteristics.

We conducted a descriptive, analytic, retrospective cohort study at a single center. The study included patients with PHA who were followed up at the Department of Endocrinology, Diabetology, and Nutrition in a hospital affiliated with Mohamed the First University of Oujda (CERBO), admitted between December 2014 and August 2023. Data were retrospectively collected from patient records over a 9-year period, involving 27 patients with PHA confirmed by an elevated aldosterone-to-renin ratio (ARR). Persistent disease was defined by persistent hypokalemia and hypertension (blood pressure > 140/90 mm Hg) after six months. Patients were divided into two groups: Those with complete resolution of hypertension (group A) and those with persistent hypertension (group B). Data were analyzed using SPSS version 21.

The mean age of patients was 48.47 ± 10.87 years, with a female predominance (66.7%). The etiological assessment identified Conn’s adenoma in 70.4% (n = 19) of cases and bilateral adrenal hyperplasia in 29.6% (n = 8). Surgery was performed in 51.9% (n = 14) of cases, with 50% (n = 7) maintaining persistent hypertension post-surgery, while 28.6% (n = 4) showed a reduction in antihypertensive medications. Two predictive factors for persistent hypertension were identified: Age > 50 years and hypertension duration > 5 years. Predictive factors for normalization of hypertension post-surgery included systolic blood pressure (SBP) < 140 mm Hg, diastolic blood pressure (DBP) < 90 mm Hg, glomerular filtration rate (GFR) > 90 mL/min/1.75 m2, and a low incidence of diabetes and dyslipidemia.

This study demonstrates that PHA can lead to resistant hypertension, highlighting the necessity for further research in this area.

## Linked entities

- **Diseases:** primary hyperaldosteronism (MONDO:0001422), resistant hypertension (MONDO:0100078)

## Full-text entities

- **Genes:** REN (renin) [NCBI Gene 5972] {aka ADTKD4, HNFJ2, RTD}
- **Diseases:** bilateral adrenal hyperplasia (MESH:D000312), AH (MESH:D000081029), Hypertension (MESH:D006973), diabetes (MESH:D003920), secondary (MESH:D000068376), hypokalemia (MESH:D007008), Hyperaldosteronism (MESH:D006929), dyslipidemia (MESH:D050171), Conn's adenoma (MESH:D018246)
- **Chemicals:** aldosterone (MESH:D000450)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12301664/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12301664/full.md

## References

24 references — full list in the complete paper: https://tomesphere.com/paper/PMC12301664/full.md

---
Source: https://tomesphere.com/paper/PMC12301664